| Company Name: |
ShangHai Caerulum Pharma Discovery Co., Ltd.
|
| Tel: |
18149758185 18149758185 |
| Email: |
sales-cpd@caerulumpharma.com |
| Products Intro: |
Product Name:BAY-784 CAS:1631164-24-3 Purity:98% Package:10mg;100mg;1g;10g;100g;1kg
|
| Company Name: |
Guangzhou Younan Technology Co., Ltd
|
| Tel: |
020-82000279 18988941452 |
| Email: |
YN_research@163.com |
| Products Intro: |
Product Name:Cathepsin Inhibitor 1 CAS:1631164-24-3 Purity:95+/98+ Package:25mg;100mg;500mg;1g;5g
|
BAY-784 manufacturers
- BAY-784
-
- $558.00
-
2026-04-20
- CAS:1631164-24-3
- Purity: 99.75%
- Supply Ability: 10g
- BAY-784
-
- $1520.00
-
2025-07-25
- CAS:1631164-24-3
- Purity:
- Supply Ability: 10g
|
| | BAY-784 Basic information |
| Product Name: | BAY-784 | | Synonyms: | BAY-784;BAY1214784;(S)-N-((3-chloro-5-(trifluoromethyl)pyridin-2-yl)methyl)-2-cyclopropyl-1-((4-fluorophenyl)sulfonyl)-;BAY784,BAY 784;Spiro[3H-indole-3,4'-[4H]thiopyran]-5-carboxamide, N-[[3-chloro-5-(trifluoromethyl)-2-pyridinyl]methyl]-2-cyclopropyl-1-[(4-fluorophenyl)sulfonyl]-1,2,2',3',5',6'-hexahydro-, 1',1'-dioxide, (2S)- | | CAS: | 1631164-24-3 | | MF: | C29H26ClF4N3O5S2 | | MW: | 672.11 | | EINECS: | | | Product Categories: | | | Mol File: | 1631164-24-3.mol |  |
| | BAY-784 Chemical Properties |
| density | 1.60±0.1 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO: 2mg/mL, clear | | pka | 12.47±0.40(Predicted) | | form | powder | | color | white to beige | | Optical Rotation | [α]/D -120 to -100°, c =0.5 in chloroform-d | | InChIKey | PZGSYNNVPNLHQG-SANMLTNESA-N | | SMILES | O=S(CCC1(C2=C(N3S(C4=CC=C(F)C=C4)(=O)=O)C=CC(C(NCC5=C(Cl)C=C(C(F)(F)F)C=N5)=O)=C2)[C@@H]3C6CC6)(CC1)=O |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | BAY-784 Usage And Synthesis |
| Uses | BAY-784 is a gonadotropin releasing hormone receptor (GnRH-R) antagonist probe with IC50s of 21 and 24 nM for human and rat GnRH-R, respectively[1]. | | Biological Activity | BAY-784 is an orally available, non-toxic, potent, and selective antagonist of human Gonadotropin-Releasing Hormone Receptor [hGnRH-R], which is potently active in other species including rate, dogs and cynomolgus monkey. It partially lowered plasma luteinizing hormone levels in humans. BAY-784 exhibits favorable drug metabolism and pharmacokinetic (DMPK) profile thus is suitable for in vivo studies. | | in vivo | BAY-784 (0.5, 3, 10, and 30 mg/kg; 24 hours; single p.o.) suppresses the plasma luteinizing hormone (LH) concentration in ovariectomized (OVX) rats in a dose-dependent manner[1]. | Animal Model: | OVX rats[1] | | Dosage: | 0.5, 3, 10, and 30 mg/kg (Pharmacokinetic Analysis) | | Administration: | Single p.o. | | Result: | ED50=4.5 mg/kg (4/8 h).
The t1/2=13-17 h, 18 h, and 7 h for male Wistar rat, female beagle, and female cynomolgus, respectively. |
| | References | [1] GnRH-R Antagonist Probe BAY-784. |
| | BAY-784 Preparation Products And Raw materials |
|